Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study of LY3867070 in Healthy Participants
Sponsor: Eli Lilly and Company
Summary
The purpose of this study is to evaluate how well LY3867070 is tolerated and what side effects may occur in healthy participants. The study drug will be administered orally. Blood tests will be performed to investigate how the body processes the study drug and how the study drug affects the body.
Official title: A Single- and Multiple-Ascending Dose Study to Evaluate the Safety and Pharmacokinetics of LY3867070 in Healthy Participants
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
196
Start Date
2025-05-27
Completion Date
2026-08
Last Updated
2026-01-21
Healthy Volunteers
Yes
Conditions
Interventions
LY3867070
Administered orally
Placebo
Administered orally
Locations (2)
Anaheim Clinical Trials, LLC
Anaheim, California, United States
Fortrea Clinical Research Unit
Dallas, Texas, United States